| Balance Sheet of Ranbaxy Laboratories (in Rs. Cr.) |
Mar 14 |
Dec 12 |
Dec 11 |
|
| |
15 mths |
12 mths |
12 mths |
|
| EQUITIES AND LIABILITIES |
|
|
|
|
| SHAREHOLDER'S FUNDS |
|
|
|
|
| Equity Share Capital |
211.66 |
211.46 |
211.00 |
|
| Total Share Capital |
211.66 |
211.46 |
211.00 |
|
| Reserves and Surplus |
884.83 |
1,709.51 |
1,713.16 |
|
| Total Reserves and Surplus |
884.83 |
1,709.51 |
1,713.16 |
|
| Total Shareholders Funds |
1,096.49 |
1,920.97 |
1,924.16 |
|
| NON-CURRENT LIABILITIES |
|
|
|
|
| Long Term Borrowings |
2,472.19 |
1,956.81 |
952.41 |
|
| Deferred Tax Liabilities [Net] |
0.00 |
0.00 |
0.00 |
|
| Other Long Term Liabilities |
371.94 |
1,036.35 |
1,597.72 |
|
| Long Term Provisions |
131.45 |
273.90 |
229.79 |
|
| Total Non-Current Liabilities |
2,975.59 |
3,267.06 |
2,779.92 |
|
| CURRENT LIABILITIES |
|
|
|
|
| Short Term Borrowings |
3,518.88 |
2,806.80 |
2,931.00 |
|
| Trade Payables |
975.19 |
858.81 |
985.64 |
|
| Other Current Liabilities |
4,349.59 |
1,332.08 |
3,000.45 |
|
| Short Term Provisions |
188.81 |
2,783.11 |
2,699.08 |
|
| Total Current Liabilities |
9,032.46 |
7,780.80 |
9,616.17 |
|
| Total Capital And Liabilities |
13,105.04 |
12,969.93 |
14,320.93 |
|
| ASSETS |
|
|
|
|
| NON-CURRENT ASSETS |
|
|
|
|
| Tangible Assets |
1,946.05 |
1,930.84 |
1,788.26 |
|
| Intangible Assets |
66.09 |
62.69 |
78.74 |
|
| Capital Work-In-Progress |
179.18 |
146.54 |
200.49 |
|
| Other Assets |
0.00 |
0.00 |
0.00 |
|
| Fixed Assets |
2,195.77 |
2,153.12 |
2,076.12 |
|
| Non-Current Investments |
4,078.99 |
3,128.14 |
3,408.15 |
|
| Deferred Tax Assets [Net] |
0.00 |
0.00 |
0.00 |
|
| Long Term Loans And Advances |
1,077.99 |
1,010.71 |
941.23 |
|
| Other Non-Current Assets |
174.11 |
21.57 |
0.09 |
|
| Total Non-Current Assets |
7,526.86 |
6,313.54 |
6,425.59 |
|
| CURRENT ASSETS |
|
|
|
|
| Current Investments |
1.90 |
3.03 |
2.65 |
|
| Inventories |
1,695.14 |
1,731.84 |
1,655.23 |
|
| Trade Receivables |
1,237.47 |
1,435.89 |
3,682.82 |
|
| Cash And Cash Equivalents |
790.57 |
2,834.77 |
1,937.95 |
|
| Short Term Loans And Advances |
1,273.29 |
504.15 |
339.98 |
|
| OtherCurrentAssets |
579.82 |
146.71 |
276.71 |
|
| Total Current Assets |
5,578.18 |
6,656.39 |
7,895.34 |
|
| Total Assets |
13,105.04 |
12,969.93 |
14,320.93 |
|
| OTHER ADDITIONAL INFORMATION |
|
|
|
|
| CONTINGENT LIABILITIES, COMMITMENTS |
|
|
|
|
| Contingent Liabilities |
1,222.20 |
789.63 |
927.85 |
|
| CIF VALUE OF IMPORTS |
|
|
|
|
| Raw Materials |
856.70 |
717.98 |
759.27 |
|
| Stores, Spares And Loose Tools |
0.00 |
0.00 |
0.00 |
|
| Trade/Other Goods |
0.00 |
0.00 |
0.00 |
|
| Capital Goods |
45.73 |
47.25 |
56.08 |
|
| EXPENDITURE IN FOREIGN EXCHANGE |
|
|
|
|
| Expenditure In Foreign Currency |
1,435.68 |
1,402.89 |
4,771.25 |
|
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS |
|
|
|
|
| Dividend Remittance In Foreign Currency |
-- |
-- |
0.01 |
|
| EARNINGS IN FOREIGN EXCHANGE |
|
|
|
|
| FOB Value Of Goods |
3,662.18 |
3,785.69 |
5,411.48 |
|
| Other Earnings |
1,431.71 |
165.89 |
170.04 |
|
| BONUS DETAILS |
|
|
|
|
| Bonus Equity Share Capital |
146.85 |
146.85 |
146.85 |
|
| NON-CURRENT INVESTMENTS |
|
|
|
|
| Non-Current Investments Quoted Market Value |
26.61 |
48.38 |
60.96 |
|
| Non-Current Investments Unquoted Book Value |
4,048.35 |
3,026.18 |
3,306.19 |
|
| CURRENT INVESTMENTS |
|
|
|
|
| Current Investments Quoted Market Value |
1.90 |
2.05 |
2.65 |
|
| Current Investments Unquoted Book Value |
-- |
0.98 |
-- |
|
Source : Dion Global Solutions Limited
